MaxCyte, Inc. Public Float
MaxCyte, Inc. (MXCT) had Public Float of $230.70 million as of 2025-06-30, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-25
- 2025-06-30: Entity Public Float $230.70M.
- 2024-06-28: Entity Public Float $407.20M.
- 2023-06-30: Entity Public Float $467.50M.
- 2022-06-30: Entity Public Float $408.80M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $230.70M 10-K · filed 2026-03-25 |
| 2024-06-28 | $407.20M 10-K · filed 2025-03-11 |
| 2023-06-30 | $467.50M 10-K · filed 2024-03-12 |
| 2022-06-30 | $408.80M 10-K · filed 2023-03-15 |
| 2021-06-30 | $1.00B 10-K/A · filed 2022-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |